BioMED Pharmaceutical Industries

Azgoflox 400 mg ® Tablets

The latest 3rd generation fluoroquinolone, moxifloxacin antibiotic with broad spectrum bactericidal activity and that works with a unique mechanism of action that inhibits DNA replication without causing bacterial resistance.



Each Tablet contain :

  • 400mg moxifloxacin film coated tablets.
  • Community acquired pneumonia (CAP) for 10 day.
  • Acute exacerbations of chronic bronchitis (AECB) for 5 days.
  • Acute bacterial sinusitis (ABS) for 7 – 10 days.
  • Complicated intra-abdominal infections (CIAI) for 5 – 14 days.
  • Uncomplicated skin and skin structure infections (USSSI) for 7 days.
  • Complicated skin and skin structure infections (CSSSI) for 7 – 21 days
  • 1 tablet (400mg) once daily for all indications. The duration of the therapy depends on the type and severity of the infection
  • Hypersensitivity.
  • Diabetes, low. seizure threshold, hypokalemia.
  • Diarrhea from an infection with  Clostridium. difficile bacteria
  • Skeletal muscle disorder.
  • Type of abnormal heart rhythm.

A box containing 10 film coated tablets.

  • Azgoflox 400mg (moxifloxacin) is a third  generation synthetic fluoroquinolone antibiotic agent. It has bactericidal in vitro activity against a wide range of Gram-positive, Gram-negative, atypical and anaerobic pathogens.